^
    6ms
    A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=86, Recruiting, Wigen Biomedicine Technology (Shanghai) Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    Avastin (bevacizumab) • carboplatin • Zejula (niraparib) • albumin-bound paclitaxel • Aqupla (nedaplatin) • WJB001
    9ms
    A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=86, Not yet recruiting, Wigen Biomedicine Technology (Shanghai) Co., Ltd.
    New P1/2 trial
    |
    Avastin (bevacizumab) • carboplatin • Zejula (niraparib) • albumin-bound paclitaxel • Aqupla (nedaplatin) • WJB001
    12ms
    A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=210, Recruiting, Wigen Biomedicine Technology (Shanghai) Co., Ltd. | Enrolling by invitation --> Recruiting
    Enrollment status
    |
    WJB001
    almost3years
    A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=210, Enrolling by invitation, Wigen Biomedicine Technology (Shanghai) Co., Ltd. | Not yet recruiting --> Enrolling by invitation
    Enrollment open
    |
    WJB001